<DOC>
	<DOC>NCT00918138</DOC>
	<brief_summary>The purpose of this study was to compare effect of Saxagliptin as add-on to Metformin on 24-hour mean weighted glucose (MWG) to the effect of uptitrating Metformin in subjects with T2DM inadequately controlled on metformin alone.</brief_summary>
	<brief_title>Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Type 2 diabetes 1878 years of age Taking stable dose of metformin immediate release (IR) or XR ≥850 mg and ≤1500 mg as monotherapy for at least 8 weeks prior to screening Glycosylated hemoglobin A1C (A1C) 7.511.5% at screening Fasting Cpeptide: ≥1.0 ng/mL FPG≥126 mg/dl obtained at the Day 7 visit Body mass index (BMI): ≤ 40kg/m² A1C ≥ 7.0% and ≤ 11.0% obtained at the Day 7 visit for randomization Women of childbearing potential unable or unwilling to use acceptable birth control Women who are pregnant or breastfeeding Significant cardiovascular history Active liver disease Renal impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>